Table 2.
Baseline correlations between LFTs and plasma soluble markers
| Clinical measure | Marker | n | Spearman r | p‐value (adj) |
|---|---|---|---|---|
| Baseline | TNF‐RII | 174 | 0.35 | <0.001 |
| ALT | CD30 | 82 | 0.38 | 0.004 |
| TNF‐α | 212 | 0.23 | 0.009 | |
| CD163 | 189 | 0.22 | 0.018 | |
| TIM‐3 | 124 | 0.26 | 0.033 | |
| IP10 | 212 | 0.19 | 0.048 | |
| Baseline | TNF‐RII | 173 | 0.34 | <0.001 |
| GGT | IP10 | 211 | 0.23 | 0.010 |
| CD30 | 82 | 0.36 | 0.011 | |
| RANTES | 182 | −0.22 | 0.026 | |
| TIM‐3 | 123 | 0.26 | 0.036 | |
| CD27 | 123 | 0.25 | 0.038 | |
| Baseline | Neopterin | 206 | −0.36 | <0.001 |
| Bilirubin | IP10 | 212 | −0.33 | <0.001 |
| MCP‐1 | 212 | −0.30 | <0.001 | |
| CD14 | 211 | −0.28 | 0.001 | |
| IFN‐α | 206 | −0.28 | 0.001 | |
| VEGF‐D | 33 | −0.48 | 0.035 |
ALT, alanine aminotransferase; GGT, gamma‐glutamyl transferase; IFN, interferon; IP, interferon gamma‐induced protein; MCP, monocyte chemoattractant protein; RANTES, regulated on activation, normal T cell expressed and secreted; TIM, T‐cell immunoglobulin and mucin domain; TNF, tumor necrosis factor.